Evidence map›Paper›PMID 22113626›Full record

ArticleMagnetic resonance in medicine2012

In vivo monitoring of pH, redox status, and glutathione using L-band EPR for assessment of therapeutic effectiveness in solid tumors.

Andrey A Bobko, Timothy D Eubank, Jeffrey L Voorhees, Olga V Efimova, Igor A Kirilyuk, Sergey Petryakov, Dmitrii G Trofimiov, Clay B Marsh, Jay L Zweier, Igor A Grigor'ev and 2 more

Abstract read
In one paragraph

Article in Magnetic resonance in medicine, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
7.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 90 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. EPR Everywhere.Applied magnetic resonance · 2021
    Review
  12. AAngewandte Chemie (International ed. in English) · 2020
    Article
  13. Article
  14. Article
  15. Modular imaging system: Rapid scan EPR at 800 MHz.Journal of magnetic resonance (San Diego, Calif. : 1997) · 2019
    Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Andrey A BobkoDivision of Pulmonary, Allergy, Critical Care, and Sleep Medicine, The Ohio State University, Columbus, Ohio 43210, USA.
Timothy D Eubank
Jeffrey L Voorhees
Olga V Efimova
Igor A Kirilyuk
Sergey Petryakov
Dmitrii G Trofimiov
Clay B Marsh
Jay L Zweier
Igor A Grigor'ev
Alexandre Samouilov
Valery V Khramtsov
The Ohio State University · USNovosibirsk Institute of Organic Chemistry · RUNovosibirsk State University · RU

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Tasleem J Padamsee · 1985 to 2026
$132.3M
Proton Electron Double Resonance Imaging (PEDRI) of Free RadicalsR01EB004900 · NIBIB · OHIO STATE UNIVERSITY · PI ZWEIER, JAY LOUIS · 2005 to 2008
$3.4M
NanoSPINs for In Vivo EPR-Based Spectroscopy and ImagingR21HL089036 · NHLBI · OHIO STATE UNIVERSITY · PI KHRAMTSOV, VALERY V · 2009 to 2010
$790k
Spin Probes in Semipermeable Nanospheres: EPR spectroscopy & imaging of tumor pHR21CA132068 · NCI · OHIO STATE UNIVERSITY · PI KHRAMTSOV, VALERY V · 2008 to 2009
$423k
Functional Proton Electron Double Resonance ImagingR21EB009433 · NIBIB · OHIO STATE UNIVERSITY · PI KHRAMTSOV, VALERY V, SAMOUILOV, ALEXANDRE VALENTIN · 2009 to 2010
$412k
NCI NIH HHS P30 CA016058NCI NIH HHS R21 CA132068NHLBI NIH HHS R21 HL089036NIBIB NIH HHS R01 EB004900NIBIB NIH HHS R21 EB009433
6 · The paper itself

Abstract

Approach for in vivo real-time assessment of tumor tissue extracellular pH (pH(e)), redox, and intracellular glutathione based on L-band EPR spectroscopy using dual function pH and redox nitroxide probe and disulfide nitroxide biradical, is described. These parameters were monitored in PyMT mice bearing breast cancer tumors during treatment with granulocyte macrophage colony-stimulating factor. It was observed that tumor pH(e) is about 0.4 pH units lower than that in normal mammary gland tissue. Treatment with granulocyte macrophage colony-stimulating factor decreased the value of pH(e) by 0.3 units compared with PBS control treatment. Tumor tissue reducing capacity and intracellular glutathione were elevated compared with normal mammary gland tissue. Granulocyte macrophage colony-stimulating factor treatment resulted in a decrease of the tumor tissue reducing capacity and intracellular glutathione content. In addition to spectroscopic studies, pH(e) mapping was performed using recently proposed variable frequency proton-electron double-resonance imaging. The pH mapping superimposed with MRI image supports probe localization in mammary gland/tumor tissue, shows high heterogeneity of tumor tissue pH(e) and a difference of about 0.4 pH units between average pH(e) values in tumor and normal mammary gland. In summary, the developed multifunctional approach allows for in vivo, noninvasive pH(e), extracellular redox, and intracellular glutathione content monitoring during investigation of various therapeutic strategies for solid tumors.

Indexed as

AnimalsBiomarkersBreast NeoplasmsCell Line, TumorElectron Spin Resonance SpectroscopyFemaleGlutathioneGranulocyte-Macrophage Colony-Stimulating FactorHydrogen-Ion ConcentrationMiceOxidation-ReductionPrognosisTreatment OutcomeBiomarkersGlutathioneGranulocyte-Macrophage Colony-Stimulating Factor

Identifiers

PMID22113626
PMCPMC3305854
OpenAlexW2072480297

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.